Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

Inclusion Criteria

• •Patient Key Informant:
• •Age 18 and older
• •Self-identify as Black/African American
• •Diagnosed with solid tumor
• •Able to read and speak English fluently
• •Able to provide informed consent
• •Able to complete 1 survey and an in-depth interview
• •Relative Key Informant:
• •Age 18 and older
• •Spouse, blood relative, or caregiver of a cancer patient who identifies as Black/African American
• •Able to read and speak English fluently
• •Able to provide informed consent
• •Able to complete 1 survey and an in-depth interview
• •Provider Key Informant:
• •Age 18 and older
• •Physician, nurse, social worker, patient navigator, or financial counselor
• •Work in oncology setting
• •Able to read and speak English fluently
• •Able to provide informed consent
• •Able to complete 1 survey and an in-depth interview
• •Pilot Tester:
• •Age 18 and older
• •Self-identify as Black/African American
• •Able to read and speak English fluently
• •Able to provide informed consent
• •Newly diagnosed with solid tumor cancer (Stage I-IV)
• •Have not yet consulted with an oncologist regarding treatment
• •Able to complete 2 surveys and an in-depth interview